Search research articles
Contact Us
Filters
Showing results (441-450 of 606) with videos related to
Page
of 61
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
January 19, 2010
IL-4-induced transcription factor NFIL3/E4BP4 controls IgE class switching
Masaki Kashiwada, Deborah M Levy, Lisa McKeag, et al.
Synapse (New York, N.Y.)
|
September 30, 2003
High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain
Richard B Rothman, Subramaniam Jayanthi, Xiaoying Wang, et al.
Synapse (New York, N.Y.)
|
November 9, 2000
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
R B Rothman, M H Baumann, C M Dersch, et al.
European Journal of Medicinal Chemistry
|
February 21, 2012
Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activity
Malliga R Iyer, Yong Sok Lee, Jeffrey R Deschamps, et al.
Neurochemical Research
|
September 1, 1994
Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor binding
Q Ni, H Xu, J S Partilla, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 7, 2009
Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil
Dorota Zolkowska, Raka Jain, Richard B Rothman, et al.
Experimental and Clinical Psychopharmacology
|
May 7, 2014
Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys
Matthew L Banks, Clayton T Bauer, Bruce E Blough, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2003
Synthesis, opioid receptor binding, and functional activity of 5'-substituted 17-cyclopropylmethylpyrido[2',3':6,7]morphinans
Subramaniam Ananthan, Hollis S Kezar, Surendra K Saini, et al.
European Journal of Pharmacology
|
May 13, 1986
Morphine tolerance increases mu-noncompetitive delta binding sites
R B Rothman, J A Danks, A E Jacobson, et al.
Bioorganic & Medicinal Chemistry
|
December 17, 2009
Probes for narcotic receptor mediated phenomena. 40. N-substituted cis-4a-ethyl-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-8-ols
Malliga R Iyer, Yong Sok Lee, Jeffrey R Deschamps, et al.
Page
of 61
Search research articles
Search
Showing results (441-450 of 606) with videos related to
Sort By:
Page
of 61
Proceedings of the National Academy of Sciences of the United States of America
|
January 19, 2010
IL-4-induced transcription factor NFIL3/E4BP4 controls IgE class switching
Masaki Kashiwada, Deborah M Levy, Lisa McKeag, et al.
Synapse (New York, N.Y.)
|
September 30, 2003
High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain
Richard B Rothman, Subramaniam Jayanthi, Xiaoying Wang, et al.
Synapse (New York, N.Y.)
|
November 9, 2000
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin
R B Rothman, M H Baumann, C M Dersch, et al.
European Journal of Medicinal Chemistry
|
February 21, 2012
Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activity
Malliga R Iyer, Yong Sok Lee, Jeffrey R Deschamps, et al.
Neurochemical Research
|
September 1, 1994
Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor binding
Q Ni, H Xu, J S Partilla, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 7, 2009
Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil
Dorota Zolkowska, Raka Jain, Richard B Rothman, et al.
Experimental and Clinical Psychopharmacology
|
May 7, 2014
Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys
Matthew L Banks, Clayton T Bauer, Bruce E Blough, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 5, 2003
Synthesis, opioid receptor binding, and functional activity of 5'-substituted 17-cyclopropylmethylpyrido[2',3':6,7]morphinans
Subramaniam Ananthan, Hollis S Kezar, Surendra K Saini, et al.
European Journal of Pharmacology
|
May 13, 1986
Morphine tolerance increases mu-noncompetitive delta binding sites
R B Rothman, J A Danks, A E Jacobson, et al.
Bioorganic & Medicinal Chemistry
|
December 17, 2009
Probes for narcotic receptor mediated phenomena. 40. N-substituted cis-4a-ethyl-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-8-ols
Malliga R Iyer, Yong Sok Lee, Jeffrey R Deschamps, et al.
Page
of 61